Healthcare -
Biotechnology - NASDAQ - US
$ 0.884
1.03 %
$ 69.2 M
Market Cap
5.53
P/E
CTMX - LONG-TERM DEBT
Long-term Debt CTMX - CytomX Therapeutics, Inc.
9.38 M
LAST VALUE
-49.02%
2 YEAR CAGR
0.00%
5 YEAR CAGR
12.29%
10 YEAR CAGR